PARPRELA Trademark

Trademark Overview

On Tuesday, February 11, 2014, a trademark application was filed for PARPRELA with the United States Patent and Trademark Office. The USPTO has given the PARPRELA trademark a serial number of 86190615. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 8, 2022. This trademark is owned by AstraZeneca AB. The PARPRELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders
parprela

General Information

Serial Number86190615
Word MarkPARPRELA
Filing DateTuesday, February 11, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 8, 2022
Registration Number4820532
Registration DateTuesday, September 29, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, inflammation, infection, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, April 8, 2022CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 29, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 29, 2015REGISTERED-PRINCIPAL REGISTER
Monday, August 24, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, July 15, 2015NOTICE OF ALLOWANCE CANCELLED
Sunday, August 23, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 15, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, February 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 17, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 17, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 4, 2014ASSIGNED TO EXAMINER
Wednesday, October 29, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 23, 2014ASSIGNED TO LIE
Thursday, October 23, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 22, 2014NON-FINAL ACTION E-MAILED
Thursday, May 22, 2014NON-FINAL ACTION WRITTEN
Saturday, May 17, 2014ASSIGNED TO EXAMINER
Monday, February 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 14, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

parprela diseases disorders substances preparations pharmaceutical infection gastrointestinal system nervous inflammation